Physician profile
Ridwan Shabsigh
NPI 1982713871
$881.80
in general payments reported to CMS, 2019-2025
8 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $21.43 · 2021: $83.68 · 2022: $38.66 · 2023: $34.18 · 2024: $119 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $315.29 | 2019-2025 | Ams 700, Ams 700 Cxr Rte Kit |
| Endo Pharmaceuticals INC. | $177.01 | 2019-2022 | |
| Baxter Healthcare | $138.65 | 2025 | |
| Teleflex LLC | $102.64 | 2024-2025 | Quikclot, Urolift |
| Zap Surgical Systems, INC. | $83.68 | 2021 | |
| Blue Earth Diagnostics | $31.73 | 2019 | |
| Endo USA, INC. | $17.25 | 2024 | Aveed, Xiaflex, Edex |
| Amgen INC. | $15.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ridwan Shabsigh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.